Missense mutations in EDA and EDAR genes cause dominant syndromic tooth agenesis.


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
01 2021
Historique:
revised: 28 10 2020
received: 19 08 2020
accepted: 29 10 2020
pubmed: 19 11 2020
medline: 3 8 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

Hypohidrotic ectodermal dysplasia (HED) is the most common form of ectodermal dysplasia and is mainly associated with mutations in the EDA, EDAR, and EDARADD responsible for the development of ectodermal-derived structures. HED displays different modes of inheritance according to the gene that is involved, with X-linked EDA-related HED being the most frequent form of the disease. Two families with tooth agenesis and manifestations of HED underwent clinical examination and EDA, EDAR, and EDARADD genetic analysis. The impact of the novel variant on the protein was evaluated through bioinformatics tools, whereas molecular modeling was used to predict the effect on the protein structure. A novel missense variant was identified in the EDAR (c.287T>C, p.Phe96Ser) of a female child proband and her mother, accounting for autosomal dominant HED. The genetic variant c.866G>A (p.Arg289His) in EDA, which has been previously described, was observed in the male proband of another family confirming its role in X-linked HED. The inheritance model of the missense mutation showed a different relationship with X-linked HED and non-syndromic tooth agenesis. Our findings provide evidence of variable expression of HED in heterozygous females, which should be considered for genetic counseling, and different modes of inheritance related to tooth development.

Sections du résumé

BACKGROUND
Hypohidrotic ectodermal dysplasia (HED) is the most common form of ectodermal dysplasia and is mainly associated with mutations in the EDA, EDAR, and EDARADD responsible for the development of ectodermal-derived structures. HED displays different modes of inheritance according to the gene that is involved, with X-linked EDA-related HED being the most frequent form of the disease.
METHODS
Two families with tooth agenesis and manifestations of HED underwent clinical examination and EDA, EDAR, and EDARADD genetic analysis. The impact of the novel variant on the protein was evaluated through bioinformatics tools, whereas molecular modeling was used to predict the effect on the protein structure.
RESULTS
A novel missense variant was identified in the EDAR (c.287T>C, p.Phe96Ser) of a female child proband and her mother, accounting for autosomal dominant HED. The genetic variant c.866G>A (p.Arg289His) in EDA, which has been previously described, was observed in the male proband of another family confirming its role in X-linked HED. The inheritance model of the missense mutation showed a different relationship with X-linked HED and non-syndromic tooth agenesis.
CONCLUSION
Our findings provide evidence of variable expression of HED in heterozygous females, which should be considered for genetic counseling, and different modes of inheritance related to tooth development.

Identifiants

pubmed: 33205897
doi: 10.1002/mgg3.1555
pmc: PMC7963410
doi:

Substances chimiques

EDA protein, human 0
EDAR protein, human 0
Ectodysplasins 0
Edar Receptor 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1555

Informations de copyright

© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

Références

Hum Mutat. 2011 Jan;32(1):70-2
pubmed: 20979233
Eur J Hum Genet. 2010 Jan;18(1):19-25
pubmed: 19623212
Nat Genet. 1999 Aug;22(4):366-9
pubmed: 10431241
Nature. 2001 Dec 20-27;414(6866):913-6
pubmed: 11780064
Eur J Hum Genet. 2008 Jun;16(6):673-9
pubmed: 18231121
Bioinformatics. 2007 May 1;23(9):1073-9
pubmed: 17332019
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W314-9
pubmed: 24829462
Orthod Craniofac Res. 2011 Aug;14(3):156-9
pubmed: 21771270
Nat Protoc. 2016 Jan;11(1):1-9
pubmed: 26633127
Int J Dermatol. 2010 Dec;49(12):1399-402
pubmed: 21091672
Int J Dermatol. 2018 Aug;57(8):965-972
pubmed: 29855039
Genes (Basel). 2017 Oct 05;8(10):
pubmed: 28981473
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Dent Res. 2009 Feb;88(2):126-31
pubmed: 19278982
PLoS One. 2013 Jul 25;8(7):e68370
pubmed: 23935863
J Biol Chem. 2001 Jan 26;276(4):2668-77
pubmed: 11035039
Bioinformatics. 2012 Apr 15;28(8):1166-7
pubmed: 22368248
Nat Commun. 2020 Nov 20;11(1):5918
pubmed: 33219223
Hum Mutat. 2006 Mar;27(3):255-9
pubmed: 16435307
Hum Mol Genet. 2001 Apr 15;10(9):953-62
pubmed: 11309369
J Dent Res. 2014 Apr;93(4):371-5
pubmed: 24487376
J Orofac Orthop. 2016 Jan;77(1):31-8
pubmed: 26753551
Am J Hum Genet. 2016 Oct 6;99(4):877-885
pubmed: 27666373
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Br J Dermatol. 2012 Apr;166(4):819-29
pubmed: 22032522
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):e17-e20
pubmed: 27168349
Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):211-24
pubmed: 12787560
Nat Protoc. 2017 Feb;12(2):255-278
pubmed: 28079879
Structure. 2003 Dec;11(12):1513-20
pubmed: 14656435

Auteurs

Francesca Andreoni (F)

Department of Biomolecular Sciences, University of Urbino, Fano, Italy.

Claudia Sgattoni (C)

Coordinamento Interdipartimentale Malattie Rare, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.

Daniela Bencardino (D)

Department of Biomolecular Sciences, University of Urbino, Fano, Italy.

Oriana Simonetti (O)

Clinica Dermatologica, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.

Antonino Forabosco (A)

Genomic Research Centre, Cante di Montevecchio Association, Fano, Italy.

Mauro Magnani (M)

Department of Biomolecular Sciences, University of Urbino, Fano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH